Relation between concentrations of digoxin in the myocardium and in the plasma.
作者信息
Malcolm A, Coltart J
出版信息
Br Heart J. 1977 Sep;39(9):935-8. doi: 10.1136/hrt.39.9.935.
Abstract
摘要
相似文献
1
Relation between concentrations of digoxin in the myocardium and in the plasma.心肌与血浆中地高辛浓度之间的关系。
Br Heart J. 1977 Sep;39(9):935-8. doi: 10.1136/hrt.39.9.935.
2
A fluorometric determination of myocardial digoxin at autopsy, with identification of digitalis leaf, digitoxin, and gitoxin.尸检时心肌地高辛的荧光测定法，同时鉴定洋地黄叶、洋地黄毒苷和吉他洛苷。
Am J Clin Pathol. 1969 Mar;51(3):347-57. doi: 10.1093/ajcp/51.3.347.
3
The 86 Rubidium assay method for determining plasma and tissue digitalis levels.用于测定血浆和组织洋地黄水平的86铷测定法。
Clin Sci. 1970 Sep;39(3):13P. doi: 10.1042/cs039013p.
4
Human myocardium and plasma digoxin concentration in patients on long-term digoxin therapy.长期接受地高辛治疗患者的人体心肌和血浆地高辛浓度
Int J Clin Pharmacol Biopharm. 1978 Oct;16(10):460-2.
5
The effect of acute hypokalemia on the myocardial concentration and body distribution of tritiated digoxin in the dog.急性低钾血症对犬体内氚标记地高辛心肌浓度及全身分布的影响。
J Pharmacol Exp Ther. 1971 Aug;178(2):271-81.
6
Fatal digitalis poisoning.致命的洋地黄中毒。
Acta Pharmacol Toxicol (Copenh). 1973;32(5):353-7. doi: 10.1111/j.1600-0773.1973.tb01481.x.
7
Limitations of serum digitalis levels.血清洋地黄水平的局限性。
Cardiovasc Clin. 1974;6(1):299-311.
8
[Value and limitations of the radioimmunological determination of cardioactive glycosides in clinical practice].[放射免疫法测定强心苷在临床实践中的价值与局限性]
G Ital Cardiol. 1976 Sep-Oct;6(5):753-61.
9
Localization of digoxin in sheep myocardium by immunofluorescent microscopy.通过免疫荧光显微镜法对羊心肌中地高辛进行定位
Biol Neonate. 1981;40(5-6):295-9. doi: 10.1159/000241505.
10
Plasma and myocardial digoxin concentrations in patients on oral therapy.接受口服治疗患者的血浆和心肌地高辛浓度
Br Heart J. 1969 Sep;31(5):636-40. doi: 10.1136/hrt.31.5.636.
引用本文的文献
1
Digoxin dosage in renal insufficiency: impracticality of basing it on the creatinine clearance, body weight and volume of distribution.肾功能不全时地高辛的剂量：基于肌酐清除率、体重和分布容积来确定剂量并不实际。
Eur J Clin Pharmacol. 1980 Nov;18(5):433-41. doi: 10.1007/BF00636799.
2
Digoxin concentration in right atrial myocardium, skeletal muscle and serum in man: influence of atrial rhythm.人体右心房心肌、骨骼肌和血清中的地高辛浓度：心房节律的影响。
Eur J Clin Pharmacol. 1980 Apr;17(4):243-50. doi: 10.1007/BF00625797.
3
Skeletal muscle digoxin concentration and its relation to serum digoxin concentration and cardiac effect in healthy man.健康男性骨骼肌中地高辛浓度及其与血清地高辛浓度和心脏效应的关系。
Eur J Clin Pharmacol. 1981 Jan;19(2):89-95. doi: 10.1007/BF00568394.
4
A standard approach to compiling clinical pharmacokinetic data.一种汇编临床药代动力学数据的标准方法。
J Pharmacokinet Biopharm. 1981 Feb;9(1):59-127. doi: 10.1007/BF01059343.
5
The drug treatment of atrial fibrillation.心房颤动的药物治疗
Br J Clin Pharmacol. 1991 Sep;32(3):267-73. doi: 10.1111/j.1365-2125.1991.tb03898.x.
6
Tissues concentration and excretion of deslanatoside C-3H in newborn and growing rabbits.去乙酰毛花苷C-3H在新生及生长中兔体内的组织浓度与排泄情况
Naunyn Schmiedebergs Arch Pharmacol. 1978 Mar;302(1):73-6. doi: 10.1007/BF00586600.
本文引用的文献
1
The distribution and concentration of tritiated digoxin in human tissues.氚标记地高辛在人体组织中的分布与浓度。
Ann Intern Med. 1967 Jan;66(1):116-24. doi: 10.7326/0003-4819-66-1-116.
2
Binding of digitoxin and some related cardenolides to human plasma proteins.洋地黄毒苷及一些相关强心甾类与人体血浆蛋白的结合
J Clin Invest. 1969 Jun;48(6):1041-53. doi: 10.1172/JCI106060.
3
Drug therapy. Serum drug concentrations as therapeutic guides.药物治疗。作为治疗指导的血清药物浓度。
N Engl J Med. 1972 Aug 3;287(5):227-31. doi: 10.1056/NEJM197208032870505.
4
Renal tubular secretion of digoxin.地高辛的肾小管分泌
Circulation. 1974 Jul;50(1):103-7. doi: 10.1161/01.cir.50.1.103.
5
Myocardial and skeletal muscle concentrations of digoxin in patients on long-term therapy.长期接受治疗的患者心肌和骨骼肌中的地高辛浓度。
Br Med J. 1972 May 6;2(5809):318-9. doi: 10.1136/bmj.2.5809.318.
6
Digitalis intoxication--diagnosis, management and prevention.洋地黄中毒——诊断、处理与预防
Cardiovasc Clin. 1974;6(2):153-74.
7
The use of serum concentrations of digitalis for quantitative therapeutic decisions.利用洋地黄血清浓度进行定量治疗决策。
Cardiovasc Clin. 1974;6(2):141-51.
8
Digitalis (third of four parts).洋地黄（四分之三部分）。
N Engl J Med. 1973 Nov 15;289(20):1063-72. doi: 10.1056/NEJM197311152892005.
9
Digitalis glycosides. Pharmacokinetics and their clinical implications.洋地黄苷类。药代动力学及其临床意义。
Ann Intern Med. 1973 Aug;79(2):229-38. doi: 10.7326/0003-4819-79-2-229.
10
Digitalis glycosides. 2.洋地黄苷。2.
N Engl J Med. 1973 May 3;288(18):942-6. doi: 10.1056/NEJM197305032881805.
Zotero 插件